Cargando…
Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma
Autores principales: | Quivoron, Cyril, Tarabay, Anthony, Michot, Jean-Marie, Pagès, Arnaud, Lecourt, Hélène, Aupérin, Anne, Danu, Alina, Lazarovici, Julien, Rossignol, Julien, Ghez, David, Dartigues, Peggy, Vergé, Véronique, Massard, Christophe, Camara-Clayette, Valérie, Ribrag, Vincent, Sarkozy, Clémentine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335111/ https://www.ncbi.nlm.nih.gov/pubmed/35320922 http://dx.doi.org/10.3324/haematol.2021.280464 |
Ejemplares similares
-
Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma
por: Michot, Jean-Marie, et al.
Publicado: (2021) -
Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study
por: Andreozzi, Fabio, et al.
Publicado: (2023) -
CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy
por: Michot, Jean-Marie, et al.
Publicado: (2021) -
Repeated courses of low‐dose 2 × 2 Gy radiation therapy in patients with indolent B‐cell non‐Hodgkin lymphomas
por: Saleh, Khalil, et al.
Publicado: (2020) -
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method
por: Flieswasser, Tal, et al.
Publicado: (2019)